The estimated Net Worth of Glenn Coleman is at least $10.2 Million dollars as of 20 November 2023. Mr. Coleman owns over 10,000 units of Integra Lifesciences Corp stock worth over $1,294,762 and over the last 16 years he sold IART stock worth over $5,813,380. In addition, he makes $3,120,420 as Chief Operating Officer and Executive Vice President at Integra Lifesciences Corp.
Glenn has made over 32 trades of the Integra Lifesciences Corp stock since 2011, according to the Form 4 filled with the SEC. Most recently he bought 10,000 units of IART stock worth $297,000 on 20 November 2023.
The largest trade he's ever made was exercising 25,658 units of Integra Lifesciences Corp stock on 16 April 2021 worth over $498,022. On average, Glenn trades about 1,811 units every 48 days since 2008. As of 20 November 2023 he still owns at least 73,566 units of Integra Lifesciences Corp stock.
You can see the complete history of Mr. Coleman stock trades at the bottom of the page.
Glenn G. Coleman serves as Chief Operating Officer, Executive Vice President of the Company. Mr. Coleman oversees Integra operations and approximately 60% of Integra’s talent force, including clinical, R&D, manufacturing, quality, and business development while also leading our international team. Prior to his promotion in June 2019 to Chief Operating Officer, he acted as the Company’s Chief Financial Officer responsible for the finance department, including accounting and financial reporting, budgeting, internal audit, tax, treasury, investor relations, and information technology while also leading our international business. Prior to joining the Company in May 2014 as Corporate Vice President, Chief Financial Officer, he spent 25 years in financial management positions with leading global businesses, including serving as vice president for finance and corporate controller at Curtiss-Wright Corporation. He also worked at Alcatel-Lucent in various finance executive leadership positions. Mr. Coleman began his career at PricewaterhouseCoopers LLP as lead senior manager for a top global account. Mr. Coleman received his B.S. degree from Montclair State University and has also been a CPA in New Jersey for more than 25 years.
As the Chief Operating Officer and Executive Vice President of Integra Lifesciences Corp, the total compensation of Glenn Coleman at Integra Lifesciences Corp is $3,120,420. There are 1 executives at Integra Lifesciences Corp getting paid more, with Peter Arduini having the highest compensation of $7,859,420.
Glenn Coleman is 52, he's been the Chief Operating Officer and Executive Vice President of Integra Lifesciences Corp since 2019. There are 14 older and 5 younger executives at Integra Lifesciences Corp. The oldest executive at Integra Lifesciences Holdings Corp is Dr. Richard E. Caruso, 78, who is the Founder and Chairman Emeritus.
Glenn's mailing address filed with the SEC is C/O DENTSPLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE, NC, 28277.
Over the last 22 years, insiders at Integra Lifesciences Corp have traded over $397,927,161 worth of Integra Lifesciences Corp stock and bought 132,879 units worth $4,504,827 . The most active insiders traders include Neal Moszkowski, Stuart Essig, and George Soros. On average, Integra Lifesciences Corp executives and independent directors trade stock every 19 days with the average trade being worth of $668,131. The most recent stock trade was executed by Jeffrey Mosebrook on 19 August 2024, trading 1,191 units of IART stock currently worth $25,702.
integra lifesciences, a world leader in medical technology, is dedicated to limiting uncertainty for surgeons, so they can concentrate on providing the best patient care. integra offers innovative solutions in orthopedic extremity surgery, neurosurgery, spine surgery, and reconstructive and general surgery. integra's orthopedic products include devices and implants for spine, foot and ankle, hand and wrist, shoulder and elbow, tendon and peripheral nerve protection and repair, and wound repair. integra is a leader in neurosurgery, offering a broad portfolio of implants, devices, instruments and systems used in neurosurgery, neuromonitoring, neurotrauma, and related critical care. in the united states, integra is a leading provider of surgical instruments to hospitals, surgery centers and alternate care sites, including physician and dental offices. founded in 1989 integra is headquartered in plainsboro, new jersey and has over 3,500 employees worldwide. integra's common stock is li
Integra Lifesciences Corp executives and other stock owners filed with the SEC include: